Ai Health Highway, a pioneering health-tech startup, has raised $1 million in a pre-Series A funding round led by Turbostart, marking a significant milestone in the company’s growth. This round forms part of a larger $1.5 million capital raise, with participation from Rainmatter by Zerodha, The Chennai Angels, BITS BioCyTiH Foundation, and prominent angel investors.
The newly acquired funds will allow Ai Health Highway to strengthen its presence across India, pursue international regulatory approvals, and expand its portfolio of AI/ML-powered solutions in the cardio-respiratory space. These efforts are in line with the company’s mission to enhance healthcare accessibility and address the rising burden of non-communicable diseases (NCDs), which are responsible for a significant percentage of premature deaths worldwide.
About Ai Health Highway
Founded in 2018 by Satish Jeevannavar, Ai Health Highway is at the forefront of developing tech-enabled tools that aid in the early detection of NCDs. The company’s flagship product, AiSteth, is an AI-enabled stethoscope designed to revolutionize cardiac care. AiSteth empowers healthcare professionals, including non-specialists, with the ability to interpret heart sounds, aiding in more accurate and timely diagnoses.
By integrating advanced AI and signal processing, AiSteth transforms traditional stethoscopes into powerful screening tools capable of detecting serious cardiac disorders at their early stages. The device fits seamlessly into existing healthcare workflows, allowing primary care providers to capture, analyze, and share high-quality heart sound data with ease. This not only enhances diagnostic accuracy but also helps mitigate the long-standing challenges of accessibility and affordability in healthcare systems.
Also Read: OnCare, a Cancer Care Startup, Secures $1 Million in Seed Funding
Founded in 2023 by Deepak Kumar and Amar Sneh, Oncare is transforming cancer care in India by partnering with hospitals housing 50-100 beds to establish specialized oncology wings.
Ai Health Highway’s Vision
Ai Health Highway is deeply committed to addressing the global challenge posed by NCDs, with a bold vision to reduce premature deaths by 30% by 2030. With this recent funding, the company is well-equipped to accelerate its impact on cardiovascular care both in India and on the international stage.
The health-tech startup’s innovative solutions, particularly in cardio-respiratory AI, are set to transform the landscape of cardiovascular care, making healthcare more accessible, affordable, and effective in the fight against NCDs.
